The Ca2+-dependent allosteric regulation of Na+/Ca2+ exchanger (NCX) proteins represents Ca2+ interaction with the cytosolic domains, CBD1 (calcium-binding domain 1) and CBD2, which is associated either with activation, inhibition or no response to regulatory Ca2+ in a given splice variant. CBD1 contains a high affinity Ca2+-sensor (which is highly conserved among splice variants), whereas primary information upon Ca2+ binding to CBD1 is modified by alternative splicing of CBD2, yielding the diverse regulatory responses to Ca2+. To resolve the structure-dynamic determinants of splicing-dependent regulation, we tested two-domain tandem (CBD12) constructs possessing either positive, negative or no response to Ca2+ using hydrogen–deuterium exchange MS (HDX–MS), SAXS, equilibrium 45Ca2+ binding and stopped-flow kinetics. Taken together with previously resolved crystallographic structures of CBD12, the data revealed that Ca2+ binding to CBD1 rigidifies the main-chain flexibility of CBD2 (but not of CBD1), whereas CBD2 stabilizes the apo-CBD1. Strikingly, the extent and strength of Ca2+-dependent rigidification of CBD2 is splice-variant dependent, where the main-chain rigidification spans from the Ca2+-binding sites of CBD1, through a helix of CBD2 (positioned at the domains’ interface) up to the tip of CBD2 [>50 Å (1 Å=0.1 nm)] or alternatively, it stops at the CBD2 helix in the splice variant exhibiting an inhibitory response to regulatory Ca2+. These results provide a structure-dynamic basis by which alternative splicing diversifies the regulatory responses to Ca2+ as well as controls the extent and strength of allosteric signal propagation over long distance.
No takes yet. Share an insight, caveat, or question.
Giladi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: